NASDAQ:CLAR
Clarus Corporation Stock News
$6.75
-0.230 (-3.30%)
At Close: May 16, 2024
Why Clarus Therapeutics Shares Are Getting Hammered
12:00pm, Monday, 25'th Apr 2022
Clarus Therapeutics Holdings Inc (NASDAQ: CRXT) shares are trading lower by 52.82% at $0.85 after the company announced an upsized $30 million underwritten public offering at $1.10 per share. The of
Clarus Sets First Quarter 2022 Conference Call for Monday, May 9, 2022, at 5:00 p.m. ET
08:00am, Monday, 25'th Apr 2022
SALT LAKE CITY, April 25, 2022 (GLOBE NEWSWIRE) -- Clarus Corporation (NASDAQ: CLAR) (“Clarus” and/or the “Company”), a global company focused on the outdoor and consumer enthusiast markets, w
Pool Corp (POOL) Q1 Earnings Top Estimates, Gives Upbeat View
03:59pm, Friday, 22'nd Apr 2022 Zacks Investment Research
Pool Corp's (POOL) first-quarter 2022 results benefit from strong demand for outdoor living products, healthy contractor backlogs and capacity-creation initiatives.
Hasbro (HAS) Q1 Earnings Miss Estimates, Revenues Surpass
03:54pm, Tuesday, 19'th Apr 2022 Zacks Investment Research
Hasbro's (HAS) first-quarter fiscal 2022 top-line benefits from solid brand performances, including Magic:The Gathering, My Little Pony, Peppa Pig and Hasbro products for the Marvel portfolio.
Bear of the Day: PLBY Group (PLBY)
11:00am, Tuesday, 19'th Apr 2022 Zacks Investment Research
Despite the strong growth still forecast for this year and next, analysts are cutting their numbers significantly.
3 Reasons Why Growth Investors Shouldn't Overlook Clarus Corporation (CLAR)
04:45pm, Thursday, 31'st Mar 2022 Zacks Investment Research
Clarus Corporation (CLAR) could produce exceptional returns because of its solid growth attributes.
3 Reasons Why Growth Investors Shouldn't Overlook Clarus Corporation (CLAR)
02:18pm, Thursday, 31'st Mar 2022
Clarus Corporation (CLAR) could produce exceptional returns because of its solid growth attributes.
Clarus Therapeutics Holdings' (CRXT) CEO Bob Dudley on Q4 2021 Results - Earnings Call Transcript
09:17pm, Wednesday, 30'th Mar 2022
Clarus Therapeutics Holdings' (CRXT) CEO Bob Dudley on Q4 2021 Results - Earnings Call Transcript
Clarus Corporation (CLAR) Upgraded to Strong Buy: Here's What You Should Know
04:00pm, Thursday, 24'th Mar 2022 Zacks Investment Research
Clarus Corporation (CLAR) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).
Clarus Corporation (CLAR) Upgraded to Strong Buy: Here's What You Should Know
01:33pm, Thursday, 24'th Mar 2022
Clarus Corporation (CLAR) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).
Is Clarus Corporation (CLAR) a Solid Growth Stock? 3 Reasons to Think " Yes "
04:45pm, Tuesday, 15'th Mar 2022 Zacks Investment Research
Clarus Corporation (CLAR) is well positioned to outperform the market, as it exhibits above-average growth in financials.
Is Clarus Corporation (CLAR) a Solid Growth Stock? 3 Reasons to Think " Yes "
02:18pm, Tuesday, 15'th Mar 2022
Clarus Corporation (CLAR) is well positioned to outperform the market, as it exhibits above-average growth in financials.
Wall Street Analysts Believe Clarus Corporation (CLAR) Could Rally 57%: Here's is How to Trade
02:00pm, Monday, 14'th Mar 2022 Zacks Investment Research
The average of price targets set by Wall Street analysts indicates a potential upside of 56.9% in Clarus Corporation (CLAR). While the effectiveness of this highly sought-after metric is questionable,
Analyst Ratings For Clarus
08:04pm, Tuesday, 08'th Mar 2022 Benzinga
Clarus (NASDAQ:CLAR) has observed the following analyst ratings within the last quarter:
Bullish
Somewhat Bullish
Indifferent
Somewhat Bearish
Bearish
Total Ratings
2
2
0
0
0
Last 30D
1
1
0
Clarus (CLAR) Q4 Earnings & Revenues Top Estimates, Stock Up
04:04pm, Tuesday, 08'th Mar 2022 Zacks Investment Research
Clarus (CLAR) fourth-quarter 2021 results benefit from robust sales performance in the Outdoor segment and Precision Sport.
